Cytox launches collaboration agreement with Mayo Clinic to evaluate novel genetic based approaches for assessing Alzheimer’s risk

Important research collaboration for pioneering PRS approach Oxford & Manchester, UK. Cytox, a precision medicine front-runner which today is commercializing polygenic risk scoring (PRS) approaches for assessing genetic risk for developi...

New Early-Warning Device To Detect Infection In Dialysis Patients Completes Successful Clinical Pilot In Manchester

Manchester - 8th May 2018.  An innovative solution designed to identify infection in dialysis patients has completed a successful pilot clinical investigation following a funding award from Health Innovation Manchester. Manchester-based medi...

Cytox in Collaboration with AKESOgen Extends Genetic Test for Assessing Alzheimer's Risk to Include Saliva Samples

Pioneering PRS approach verified for banked DNA, blood and saliva samples OXFORD, England & MANCHESTER, England & ATLANTA--(BUSINESS WIRE)--Cytox, a precision medicine testing company commercializing polygenic risk scoring (PRS) and other...

Maxwellia announces funding to accelerate its mission for Self Care

Alderley Park, UK, 26 March 2018 – Maxwellia, a pioneering ‘prescription to over the counter’ medicines company, today announced that it has raised £700,000 in early-stage investment from the GM&C Life Sciences Fun...

Renephra Secures Investment from Deepbridge Capital and Catapult Ventures

Manchester UK, 21st March 2018 - Renephra, a medical device company, today announced that it has raised £231,000 from Deepbridge Capital and the GM&C Life Sciences Fund, managed by Catapult Ventures. Renephra, spun out of The Unive...

From our portfolio


Healthcare Technology

viewview our portfolio

Our Team

Duncan Cameron

view complete team

Contact us

Alderley Park
Alderley Edge
SK10 4TG

Tel: 01625 344300